Dermata Therapeutics, Inc. (DRMA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.47M | 7.86M | 5.07M | 6.48M | 10.01M | 3.53M | 6.69M | 5.24M | 5.18M | 7.98M | 7.32M | 8.71M | 9.3M | 6.94M | 8.97M | 11.03M | 9.04M | 11.62M | 13.69M | 1.14M |
| Cash & Short-Term Investments | 6.95M | 7.52M | 4.66M | 6.48M | 9.72M | 3.16M | 6.14M | 4.95M | 4.73M | 7.44M | 6.63M | 8.44M | 8.77M | 6.24M | 8.07M | 10.63M | 8.19M | 10.8M | 12.6M | 427.2K |
| Cash Only | 6.95M | 7.52M | 4.66M | 6.48M | 9.72M | 3.16M | 6.14M | 4.95M | 4.73M | 7.44M | 6.63M | 8.44M | 8.77M | 6.24M | 8.07M | 10.63M | 8.19M | 10.8M | 12.6M | 427.2K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.36K | 0 | 0 | 6.36K | 12.6K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 93.09K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 95.37K | 53.84K | 0 | 0 | 2K | 12.6K | 0 | 144.29K | 92.9K | -8.36K | 76.29K | 67.5K | 80.87K | 11.6K | 12.89K | 0 | 179.59K | 55.72K | 0 | 687.33K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 677.8K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 677.8K |
| Total Assets | 7.47M | 7.86M | 5.07M | 6.64M | 10.01M | 3.53M | 6.69M | 5.24M | 5.18M | 7.98M | 7.32M | 8.71M | 9.3M | 6.94M | 8.97M | 11.03M | 9.04M | 11.62M | 13.69M | 1.14M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -25.38% | 122.53% | -24.16% | 26.81% | 93.16% | -55.71% | -8.69% | -39.9% | -44.27% | 14.89% | -18.4% | -20.98% | 2.78% | -40.26% | -34.42% | 869.9% | 447.73% | 1819.87% | - | - |
| Total Current Liabilities | 1.05M | 1.64M | 1.11M | 413.69K | 2.7M | 1.97M | 1.95M | 1.92M | 1.37M | 1.62M | 916.82K | 682.86K | 1.21M | 922.63K | 1.5M | 1.37M | 1.19M | 1.52M | 1.2M | 1.64M |
| Accounts Payable | 318.33K | 460.81K | 453.43K | 413.69K | 1.4M | 808.01K | 863.6K | 1.33M | 822.55K | 866.03K | 474.46K | 437.78K | 492.87K | 496.7K | 483.74K | 608.81K | 662.23K | 515.25K | 769.86K | 881.31K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 174.84K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 449.54K | 200.18K | 0 | -121.88K | 0 | 0 | 327.24K | 0 | 0 | 716.49K | 0 | 0 | 131.26K | 170.39K | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 7.09x | 4.79x | 4.56x | 15.67x | 3.70x | 1.79x | 3.44x | 2.73x | 3.78x | 4.91x | 7.99x | 12.76x | 7.70x | 7.53x | 5.97x | 8.07x | 7.59x | 7.66x | 11.45x | 0.69x |
| Quick Ratio | 7.00x | 4.79x | 4.56x | 15.67x | 3.70x | 1.79x | 3.44x | 2.73x | 3.78x | 4.91x | 7.99x | 12.76x | 7.70x | 7.53x | 5.97x | 8.07x | 7.59x | 7.66x | 11.45x | 0.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 612.58K | 0 | 0 | 1.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 612.58K | 0 | 0 | 1.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.05M | 1.64M | 1.11M | 1.03M | 2.7M | 1.97M | 1.95M | 1.92M | 1.37M | 1.62M | 916.82K | 682.86K | 1.21M | 922.63K | 1.5M | 1.37M | 1.19M | 1.52M | 1.2M | 1.64M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 174.84K |
| Net Debt | -6.95M | -7.52M | -4.66M | -6.48M | -9.72M | -3.16M | -6.14M | -4.95M | -4.73M | -7.44M | -6.63M | -8.44M | -8.77M | -6.24M | -8.07M | -10.63M | -8.19M | -10.8M | -12.6M | -252.36K |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.06x | -2630.21x | -729.55x |
| Total Equity | 6.41M | 6.22M | 3.96M | 5.61M | 7.3M | 1.56M | 4.74M | 3.32M | 3.81M | 6.36M | 6.41M | 8.03M | 8.09M | 6.02M | 7.47M | 9.66M | 7.85M | 10.11M | 12.49M | -505.8K |
| Equity Growth % | -12.17% | 298.65% | -16.48% | 69.2% | 91.73% | -75.44% | -25.99% | -58.68% | -52.92% | 5.53% | -14.24% | -16.87% | 3% | -40.42% | -40.19% | 2009.83% | 1002.88% | 418.04% | - | - |
| Book Value per Share | 1.66 | 5.09 | 3.86 | 5.47 | 14.16 | 10.04 | 30.49 | 49.04 | 85.76 | 16.17 | 301.34 | 445.29 | 1230.63 | 78.19 | 1460.46 | 2070.96 | 150.42 | 12.10 | 401.28 | -10.77 |
| Total Shareholders' Equity | 6.41M | 6.22M | 3.96M | 5.61M | 7.3M | 1.56M | 4.74M | 3.32M | 3.81M | 6.36M | 6.41M | 8.03M | 8.09M | 6.02M | 7.47M | 9.66M | 7.85M | 10.11M | 12.49M | -505.8K |
| Common Stock | 402 | 266 | 84 | 64 | 603 | 252 | 168 | 69 | 666 | 26 | 319 | 319 | 239 | 77 | 1.21K | 1.01K | 833 | 833 | 833 | 191 |
| Retained Earnings | -75.08M | -73.23M | -71.37M | -69.68M | -67.98M | -65.68M | -62.52M | -59.35M | -56.52M | -53.39M | -51.25M | -49.53M | -47.83M | -45.59M | -43.92M | -41.5M | -38.77M | -35.98M | -33.43M | -31.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |